Iovance Biotherapeutics Inc at Jefferies Virtual London Healthcare Conference Transcript
Good afternoon, everyone. My name is Kelly Shi, one of the biotech research analysts at Jefferies. Thank you, everyone online, for attending our Virtual London Healthcare Conference. Today, we are very pleased that we have Ms. Maria Fardis, the Chief Executive Officer of Iovance Biotherapeutics, joining us for this fireside chat session. And at the end of the session, if time allows, we will have a Q&A. (Operator Instructions)
And thank you for joining us, Maria.
Questions & Answers
Before we get into some of the more detailed questions, maybe we can touch on the high level and then your vision or your (inaudible) for TIL therapies. You've made significant strides since becoming CEO. Do you see TILs as a therapy for earlier lines? Or do you expect these therapies will be relegated to last in line?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
